<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03065634</url>
  </required_header>
  <id_info>
    <org_study_id>93000-133</org_study_id>
    <nct_id>NCT03065634</nct_id>
  </id_info>
  <brief_title>Return to Work and Living Healthy After Head and Neck Cancer</brief_title>
  <acronym>RELIANCE</acronym>
  <official_title>Return to Work and Living Healthy After Head and Neck Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universitätsklinikum Leipzig</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jena University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum St. Georg gGmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Städtisches Klinikum Dresden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>German Cancer Aid</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Based on a randomized controlled trial, the manualized group intervention Return to work and&#xD;
      living healthy after head and neck cancer (RELIANCE) for head and neck cancer survivors will&#xD;
      be tested against a non-manualized control intervention (social counseling) in order to&#xD;
      evaluate the efficacy of the RELIANCE intervention compared to the control condition. The&#xD;
      study design includes two phases, the initial study phase (pilot study) and the intervention&#xD;
      study (RCT). The aim of the pilot study is to implement and ensure the necessary standardized&#xD;
      procedures for the implementation of patient recruitment and interventions. In the randomized&#xD;
      controlled trial, potential participants are assigned to the intervention group or to the&#xD;
      control group.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    insufficient recruitment rate&#xD;
  </why_stopped>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">September 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Open Label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Work ability</measure>
    <time_frame>directly after intervention and at six months follow-up</time_frame>
    <description>Work-Ability-Index, short version (WAI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pattern of work-related coping behaviour</measure>
    <time_frame>directly after intervention and at six months follow-up</time_frame>
    <description>Pattern of work-related coping behaviour, short Version (AVEM-44)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cancer-specific health-related quality of Life (global, functioning, symptom burden)</measure>
    <time_frame>directly after intervention and at six months follow-up</time_frame>
    <description>Quality of Life Core Questionnaire of the European Organisation for Research and Treatment of Cancer (EORTC-QLQ-C30)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life and symptoms specific to head and neck cancer</measure>
    <time_frame>directly after intervention and at six months follow-up</time_frame>
    <description>Head and Neck Module of the European Organisation for Research and Treatment of Cancer (EORTC-H&amp;N35)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anxiety, depression and psychological distress in patients with somatic diseases</measure>
    <time_frame>directly after intervention and at six months follow-up</time_frame>
    <description>Hospital Anxiety and Depression Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health behavior and health related attitudes and knowledge about specific diseases</measure>
    <time_frame>directly after intervention and at six months follow-up</time_frame>
    <description>questionnaire measuring health behavior and health related attitudes and knowledge about specific diseases (FEG)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>general self-efficacy expectation</measure>
    <time_frame>directly after intervention and at six months follow-up</time_frame>
    <description>general self-efficacy expectation (ASKU)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Head and Neck Cancer</condition>
  <arm_group>
    <arm_group_label>Manualized RELIANCE intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Return to work and living healthy after head and neck cancer (RELIANCE) is a 2-months group intervention for head and neck cancer patients delivered by a trained psychotherapist and a peer in eight sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-manualized socio-legal counseling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>two socio-legal counseling sessions delivered by a social worker</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Return to work and living healthy after head and neck cancer</intervention_name>
    <description>Return to work and living healthy after head and neck cancer (RELIANCE) is a 2-months group intervention for head and neck cancer patients delivered by a trained psychotherapist and a peer in eight sessions. The individual sessions aim to improve work ability, quality of life and psychological well-being</description>
    <arm_group_label>Manualized RELIANCE intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>socio-legal counseling</intervention_name>
    <description>Non-manualized socio-legal counseling&#xD;
two socio-legal counseling sessions delivered by a social worker</description>
    <arm_group_label>Non-manualized socio-legal counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of laryngea, hypopharyngeal, oropharyngeal, tonsil or base of the tongue&#xD;
             cancer within the last six months&#xD;
&#xD;
          -  Curative treatment&#xD;
&#xD;
          -  Completion of primary and follow-up Treatment&#xD;
&#xD;
          -  Fluency in German&#xD;
&#xD;
          -  Written informed and voluntary consent&#xD;
&#xD;
          -  Psychological distress (Distress Thermometer score &gt; 4)&#xD;
&#xD;
          -  Self-perceived prognosis of employment (SPE score ≥ 1)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Alcohol dependency with physical withdrawal symptoms (CAGE score ≥ 3 and current use&#xD;
             of alcohol)&#xD;
&#xD;
          -  Acute suicidal tendencies&#xD;
&#xD;
          -  Receiving old-age pension or will receive old-age pension within the next 12 months&#xD;
&#xD;
          -  Cognitive impairment indicated in the medical records or by the attending doctor&#xD;
&#xD;
          -  Being in psychotherapy&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Medical Center Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://medpsy.uniklinikum-leipzig.de/medpsych.site,postext,projekte-psychoonkologie-aktuell,a_id,8222.html</url>
    <description>Related Info</description>
  </link>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>February 17, 2017</study_first_submitted>
  <study_first_submitted_qc>February 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2017</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Anja Mehnert</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

